Events / Education

Cancer Imaging: An All-Inclusive Specialty 

Venue: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, 02215, MA. USA

Date:  Monday 12th to Wednesday 14th September 2022

Keynote lectures

• A Keynote Lecture by Nobel Prize Laureate William G. Kaelin Jr., MD 
• Fostering Diversity, Equity and Inclusion on a Global Level
• A Global View of The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine by Prof. Hedvig Hricak

Main sessions

• Global Cancer Imaging: perspectives from each of the seven continents 
• State-of-the-Art: Artificial Intelligence and Cancer Imaging
• Practical Cancer Imaging: Lung and Breast
• Brain and Head and Neck Cancer
• Liver Cancer
• Molecular Cancer Imaging and Theranostics
• State-of-the-Art Cancer Imaging: Pediatric Cancer Imaging, Genomics, Tumor markers
• State-of-the-Art: Immuno-oncology and Cancer Imaging
• Multidisciplinary Teams Perspectives and Expectations
• Practical Cancer Imaging: Pancreatic and Colorectal

Break-out sessions

• Cancer Imaging during the COVID-19 pandemic and Screening Incidental Chest Findings
• Practical Cancer Imaging: Kidney/Bladder/Prostate/Retroperitoneum  and  Gynecology Oncology
• Tumor Response Assessments
• Molecular Cancer Imaging and Theranostics
• Image-guided interventions
• State-of-the-Art Cancer Imaging: Pediatric Cancer Imaging and Genomics

Computer hands-on workshops Smaller classes, offered on a first come first served basis.

• Whole-body MRI
• Challenging prostate cancer cases and prostate MRI quality assessment
• Challenging renal and bladder oncology cases
• Challenging gynecology oncology cases
• Challenging brain and head/neck oncology cases
• Practice-oriented Cancer Imaging AI technology applications for clinical use
• Thyroid nodules: The role of TI-RADS
• LI-RADS made easy
• Challenging liver and pancreatic oncology cases

Scientific paper sessions and poster exhibition

Prizes for the best oral presentations and best posters will be awarded at the course party on Tuesday evening.

 

ONLINE REGISTRATION

ICIS 2022 – Welcome Reception at the Isabella Stewart Gardner Museum

The Welcome Reception on Monday 12 September will be held at the close of lectures at the Isabella Stewart Gardner Museum, a museum unlike any other! The Museum is a celebration to art in all its forms and is home to contemporary and historical exhibitions, reflecting the adventurous spirit of its founder, Isabella Stewart Gardner. Born in New York City in 1840, Isabella married Bostonian John Lowell Gardner Jr, in 1860, and their wide travels inspired a passion for art. The Museum opened in 1903 and has been delighting visitors ever since with its remarkable collection accumulated by Isabella.

The Museum is located at 25 Evans Way, Boston, MA 02115, a short taxi ride or 20-25 minute walk from the Hotel Commonwealth. We look forward to seeing you there!

 

ICIS 2022 – Course Dinner

The Course Dinner will be held on Tuesday 13 September at Morton’s Boston Seaport (2 Seaport Lane, Boston, MA 02210).

Your ticket will include a courtesy bus to transport you from the conference venue to Morton’s, which is located in the very popular Seaport area of Boston, adjacent to the waterfront. You will have the opportunity to relax and network with faculty and other participants of ICIS 2022 as you enjoy a three-course meal with drinks in the attractive Atrium area of the restaurant. There will be a choice of entrees on the night; dietary requirements can be catered for.   

Dinner tickets are available to purchase with registration at a cost of $95 per head; please be sure to indicate any dietary restrictions.

We hope you will join us at the dinner!

 

Closest Airport: Boston Logan

General Edward Lawrence Logan International Airport, also known as Logan International Airport is located in East Boston.

 

Onward travel from Logan

Water Shuttles: Connects with Downtown Boston and other interesting places. 66 route Shuttle bus for free between Boston Dock and all the terminals at the airport.  See more information  

MBTA: Public transportation offers different options to get from and to Logan Airport. See more information

Uber and Taxi: In all terminals, taxis wait outside the arrivals level. Fare to Downtown Boston fare is approximately  $25-$45, depending on traffic / time of day. See more information

  Royal College of Radiologists – delegates will receive 18.5 credits in total for the three-day course. Monday 7 credits, Tuesday 6.5 credits, Wednesday 5 credits.

  European Accreditation Council for Continuing Medical Education (EACCME) has been applied for.

  American delegates can have their EACCME European CME Credits converted to AMA PRA Category 1 Credit™ by applying to the AMA.

Download the 1 page from here:- https://www.ama-assn.org/sites/default/files/media-browser/public/cme/eaccme-application.pdf

Send the completed  form to the AMA together with the EACCME certificate* and the non-refundable processing fee (AMA members $30 and non AMA members $75).  AMA certificates will be emailed within 3 business weeks. 

* The EACCME certificate will be automatically emailed to you once you have completed the ICIS course daily electronic surveys.

Please visit this link for further information https://www.ama-assn.org/education/uemseaccme-cme-credit-recognition

Submission deadline: Monday 1 June 2022

---

Guidelines

You may choose among four different abstract types:
> Oral Scientific Presentation
> Oral Case-Based Presentation
> Poster Scientific Presentation
> Poster Educational Presentation

Oral Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words.  Abstracts should not include promissory notes such as “We will provide additional data during our presentation.”  Authors of accepted oral presentations will be invited for an online presentation within the Scientific Sessions.  Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program). 

Oral Case-Based Presentation
The abstract should have an image and three teaching points. The abstract limit is 250 words.  Abstracts should not include promissory notes such as “We will provide additional data during our presentation.”  Authors of accepted oral case-based presentations will be invited for an online presentation within the Scientific Sessions.  Presentation time will be 8 minutes with 2 minutes for Q&A (depending on the final program). 

Poster Scientific Presentation
The abstract should be separated into “Aim”, “Methods”, “Results” and “Conclusion”. The abstract limit is 250 words. 

Poster Educational Presentation
The abstract should be separated into “Learning Objectives”, “Content Organisation”, and “Conclusion”. The abstract limit is 250 words. 

Abstracts that do not adhere to the following important points will be rejected:

> The title should not exceed 15 words. The title should be in bold, sentence case with no full stop at the end and no underlining.
> The abstract should not exceed 250 words.
> Please use authors’ initials and surnames only. No full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from a number of different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author's name, e.g.: John Smith¹, Susan Jones², Bill Fisher³. An asterisk * should be used to link the corresponding author with their email address
> Affiliations should include institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names (see above paragraph) and show the appropriate superscript number, e.g.:

           ¹ University, Town, State, USA
           ² University, Town, UK
           ³ Company, Town, Country

> Qualifications should be omitted.  
> Do not include references, tables or figures.
> Please do not use block capitals.

Main text

In structured abstracts, paragraph headings should be typed in bold with no colon at the end. Do not use the heading ‘Abstract’. Each heading should be in a separate paragraph.

Aim

Followed by regular text, on a new line and in the same format as shown above for main text.

Materials & Methods

Results

Conclusions

Consent to publish If the abstract contains details relating to individual participants (for example a case report), written informed consent for the publication of these details must be obtained from the participants and a statement to this effect should appear at the end of the abstract. Our guidelines for consent statements can be found here: http://www.biomedcentral.com/about/editorialpolicies#Ethics.

If the patient is deceased consent for publication should be obtained from the next of kin and if the patient is under 16 consent should be obtained from the parent or guardian.

Please find examples below

---

Proceedings of the 21st International Cancer Imaging Society Annual Teaching Course

Abstracts selected for presentation will be published in the Proceedings of the 21st International Cancer Imaging Society Annual Teaching Course, which will be made available online for all faculty and delegates. A downloadable version of your submission will be made available to our membership on the members only area of our website, and will be available on the Cancer Imaging open access website. Authors of selected abstracts will be notified by 1st July 2022.

It will be obligatory for all scientific presenters to be members of ICIS at the time of online presentation. The annual membership fee of $110 will be added to the scientific presenters’ fee at registration if current membership is not in place. Please note that we have a discounted trainee membership at $55 for those who send a letter from their Head of Department, confirming their trainee status. Membership will run for one year from date of registration; all standard member benefits will apply.

Financial help will be available for junior proffered presenters. This will be decided on application and on a case-by-case basis.  

Applicants for financial aid please email admin@icimagingsociety.org.uk for further information.

Queries may be addressed to the ICIS Secretariat by email to: admin@cancerimagingsociety.org.uk

Examples

---

EXAMPLE – ORAL CASE BASED PRESENTATION

Diagnosis: Advanced Cervix Cancer

Sala E.

Memorial Sloan Kettering Cancer Center, New York, USA

Images:

Teaching/Discussion points:

> Discuss the role of MRI in treatment slection and planning of patients with cervical cancer
> Describe MRI Features of parametrial and pelvic sidewall invasion
> Highlight potential pitfalls

EXAMPLE - POSTER EDUCATIONAL

Chemotherapy induced cardiomyopathy: an overview, imaging features, and future prospective

Firstname A Lastname1*, Firstname B Lastname2, Firstname C Lastname3

1University, Town, State, USA
2University, Town, UK
3Company, Town, Canada

*Email address of corresponding author if being included

Learning objectives:

To review the spectrum of imaging findings of chemotherapy- induced cardiomyopathy in correlation with most common cytotoxic drugs and regimens. 

Content organisation:

Cardio toxic effect of chemotherapy is a well-recognized problem in cancer patients.  Cardio toxicity depends on multiple predisposing factors, specific components of the chemotherapy regimen, length of treatment, and dosage.

We will present the spectrum of most common cardiotoxic chemotherapy agents and their combinations, specific effects on the myocardium, and imaging features of cardiomyopathies induced by chemotherapy.

We will review pathophysiology of chemotherapy induced cardiomyopathy including:

- Dose dependent cardiomyopathy

- Predisposing conditions –diabetes, presence of coronary artery disease, age.

- Potential reversibility

We will discuss imaging characteristics of chemotherapy induced cardiomyopathy

- Imaging modalities ( Echocardiography, Cardiac MR, and MUGA)

- Importance of monitoring cardiac function during and after treatment

- Distribution of late Gadolinium enhancement (LGE)

- Emerging technologies for early diagnosis of cardiomyopathy in cancer patients

Conclusions:

Chemotherapy induced cardiomyopathy is a common problem among cancer patients, increasing long term morbidity and mortality and often leading to disability. Patients receiving chemotherapy treatment, particularly cardio toxic agents, should be routinely assessed for cardiac function to diagnose cardiomyopathy during the early phase of treatment and to prevent development of irreversible heart failure.

EXAMPLE POSTER SCIENTIFIC

The value of 68Ga-PSMA enhanced MR-PET in patients with biochemical recurrent prostate cancer

Firstname A Lastname1*, Firstname B Lastname2, Firstname C Lastname3

1University, Town, State, USA
2University, Town, UK
3Company, Town, Canada

*Email address of corresponding author if being included

Aim:  In patients with prostate Cancer increased levels of PSMA can be measured. Recently a new tracer, ⁶⁸Ga-PSMA, was developed as a specific marker for hybrid imaging (PET/CT, MR-PET). In this study we evaluated the accuracy of ⁶⁸Ga-PSMA in patients with rising PSA after radical prosatectomy, so called „biochemical recurrent prostate cancer“ (BRPC).

Materials and Methods:  A total of 322 patients with BRPC underwent a MR-PET examination (Siemens Biograph mMR) after injection of about 150 mBq ⁶⁸Ga-PSMA. Images were evaluated in cosensus by one experienced nuclear medicine physician  and one radiologist. Pelvine lymphnode dissection was performed in most of the patients according to a predefined template with 8 fields. Lymphnode involvement was evaluated according to a 5 point scale with a patient-  and a field-based analysis.  These findings were startified according to PSA-values.

Results:  Four patients were excluded from the study for different reasons. Sensitivity for detection of recurrence was 95.7 % for PSA-values ≥ 2ng/ml, 81.4 % for PSA-values of 1-2 ng/ml, 76% for PSA-values 0.5-1 ng/ml, and 51% for PSA values ≤ 0.5 ng/ml. In comparison to the MR-images alone MR-PET was of superior diagnostic value.

Conclusions:  MR-PET using ⁶⁸Ga-PSMA is a sensitive and highly accurate technique for the diagnosis of  biochemical reccurence of prostate cancer after radical prostatectomy. It yields high diagnostic performance at relatively low PCA-values.

Don’t take our word for it. Read what our delegates said about our previous annual teaching course: • Very informative course for up to date knowledge on complex oncological imaging. • Incredible conference with a really friendly atmosphere.  The workshops give you a real insight into how to implement the techniques in practice. • I strongly recommend this fantastic course. • Excellent for learning, updating and inspiration to the challenges in your daily practice and also a very social meeting. • The best Oncology Imaging meeting out there.  This is a must – attend meeting for anyone interested in oncology related imaging • Excellent and productive course. • Inspiring meeting. • Great! Covers topics general radiologists need to know and do not easily find elsewhere. • This was a highly informative conference in which it was easy to speak with experts in all fields informally at the breaks.  I would highly recommend it. • Excellent.  Strong case-based lectures with excellent literature references. • Excellent speakers, great topics and great people, what more can you ask? • Great conference with the latest cancer imaging information including criteria, protocol, modalities etc.  Great information for the clinical trial in oncology using imaging. Amazing! • ICIS annual meeting is the place you can keep learning and create new projects in order to continue with your education in Oncological Imaging. • A very well organised excellent course with superb speakers. • Excellent cancer imaging forum that meets practice, academic and research needs.  I have attended 14th, 15th, 16th and 18th Annual Teaching Courses.  My knowledge has grown and I have shared this with colleagues from all over the world. • Very good course.  Highly recommended.

Applications are invited for sponsorship to cover registration fees to participate in ICIS 2022, 12-14 September 2022, in Boston, MA. ICIS 2022 will be the 21st Annual Teaching Course of our Society and the first to be held in the USA. With the theme ‘Cancer Imaging: An All-Inclusive Specialty’, the three-day programme will include the perspectives of imaging from all seven continents of the world! 

We would like to have a sponsored delegate representing as many of the continents as possible, to share this opportunity globally and therefore we welcome applications to secure sponsorship to join us for ICIS 2022! 

Please email admin@cancerimagingsociety.org.uk with a description of how participating in ICIS 2022 will benefit your practice; entitle your email ‘ICIS 2022 sponsorship application’ and include a copy of your CV. Trainees should also submit a letter of support from their Head of Department.

The deadline for applications is Monday 4 July 2022.

You will be notified by 11 July 2022 whether or not your application has been successful, and whether support will cover virtual participation or attendance in-person at the three-day course. 

Meeting Sponsors Platinum sponsor: Bracco Gold sponsor: GE Silver sponsors: Guerbet, Lantheus, PETNET Solutions Inc., Siemens Healthineers Bronze sponsors: AI Metrics, Ashvattha Therapeutics, Centre for Probe Development & Commercialization, Hermes Medical Solutions, Hologic, IBA RadioPharma Solutions, ImaginAb, MIM Software Inc., Mint Medical, Visage Imaging. Supported by a grant from Pfizer Inc.